BDBM703749 2-[1-[(2S)-4-[3- fluoro-5-isobutyl-2- (2H-tetrazol-5-yl)- phenyl]-2-methyl- piperazin-1-yl]- ethyl]-5-methyl- thiazole::US20240368133, Compound A-226
SMILES Cc1cnc(C(C)N2CCN(c3cc(CC(C)C)cc(F)c3-c3nn[nH]n3)C[C@@H]2C)s1
InChI Key InChIKey=AUPWVUVSQKOZSY-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 703749
TargetType-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor(Human)
Confo Therapeutics
US Patent
Confo Therapeutics
US Patent
Affinity DataIC50: 37.2nMAssay Description:All synthesized ligands were evaluated in a radioligand assay by displacing 125I-[Sar1, Ile8]-Angiotensin II (Perkin Elmer, NEX248050UC) from human A...More data for this Ligand-Target Pair